182 related articles for article (PubMed ID: 16551269)
1. TYK2 activity promotes ligand-induced IFNAR1 proteolysis.
Marijanovic Z; Ragimbeau J; Kumar KG; Fuchs SY; Pellegrini S
Biochem J; 2006 Jul; 397(1):31-8. PubMed ID: 16551269
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor.
Kumar KG; Krolewski JJ; Fuchs SY
J Biol Chem; 2004 Nov; 279(45):46614-20. PubMed ID: 15337770
[TBL] [Abstract][Full Text] [Related]
3. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
Ragimbeau J; Dondi E; Alcover A; Eid P; Uzé G; Pellegrini S
EMBO J; 2003 Feb; 22(3):537-47. PubMed ID: 12554654
[TBL] [Abstract][Full Text] [Related]
4. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
[TBL] [Abstract][Full Text] [Related]
6. Ligand-independent pathway that controls stability of interferon alpha receptor.
Liu J; Plotnikov A; Banerjee A; Suresh Kumar KG; Ragimbeau J; Marijanovic Z; Baker DP; Pellegrini S; Fuchs SY
Biochem Biophys Res Commun; 2008 Mar; 367(2):388-93. PubMed ID: 18166147
[TBL] [Abstract][Full Text] [Related]
7. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.
Kumar KG; Tang W; Ravindranath AK; Clark WA; Croze E; Fuchs SY
EMBO J; 2003 Oct; 22(20):5480-90. PubMed ID: 14532120
[TBL] [Abstract][Full Text] [Related]
8. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1.
Richter MF; Duménil G; Uzé G; Fellous M; Pellegrini S
J Biol Chem; 1998 Sep; 273(38):24723-9. PubMed ID: 9733772
[TBL] [Abstract][Full Text] [Related]
9. A role for Janus kinases in crosstalk between ErbB3 and the interferon-alpha signaling complex in myeloma cells.
Walters DK; Jelinek DF
Oncogene; 2004 Feb; 23(6):1197-205. PubMed ID: 14647450
[TBL] [Abstract][Full Text] [Related]
10. Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation.
Krishnan K; Yan H; Lim JT; Krolewski JJ
Oncogene; 1996 Jul; 13(1):125-33. PubMed ID: 8700538
[TBL] [Abstract][Full Text] [Related]
11. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase.
Yan H; Piazza F; Krishnan K; Pine R; Krolewski JJ
J Biol Chem; 1998 Feb; 273(7):4046-51. PubMed ID: 9461596
[TBL] [Abstract][Full Text] [Related]
12. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.
Gauzzi MC; Barbieri G; Richter MF; Uzé G; Ling L; Fellous M; Pellegrini S
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11839-44. PubMed ID: 9342324
[TBL] [Abstract][Full Text] [Related]
13. Catalytically active TYK2 is essential for interferon-beta-mediated phosphorylation of STAT3 and interferon-alpha receptor-1 (IFNAR-1) but not for activation of phosphoinositol 3-kinase.
Rani MR; Leaman DW; Han Y; Leung S; Croze E; Fish EN; Wolfman A; Ransohoff RM
J Biol Chem; 1999 Nov; 274(45):32507-11. PubMed ID: 10542297
[TBL] [Abstract][Full Text] [Related]
14. Identification of residues of the IFNAR1 chain of the type I human interferon receptor critical for ligand binding and biological activity.
Cajean-Feroldi C; Nosal F; Nardeux PC; Gallet X; Guymarho J; Baychelier F; Sempé P; Tovey MG; Escary JL; Eid P
Biochemistry; 2004 Oct; 43(39):12498-512. PubMed ID: 15449939
[TBL] [Abstract][Full Text] [Related]
15. The antiviral action of interferon is potentiated by removal of the conserved IRTAM domain of the IFNAR1 chain of the interferon alpha/beta receptor: effects on JAK-STAT activation and receptor down-regulation.
Basu L; Yang CH; Murti A; Garcia JV; Croze E; Constantinescu SN; Mullersman JE; Pfeffer LM
Virology; 1998 Mar; 242(1):14-21. PubMed ID: 9501047
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.
Yan H; Krishnan K; Greenlund AC; Gupta S; Lim JT; Schreiber RD; Schindler CW; Krolewski JJ
EMBO J; 1996 Mar; 15(5):1064-74. PubMed ID: 8605876
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor.
Zheng H; Qian J; Baker DP; Fuchs SY
J Biol Chem; 2011 Oct; 286(41):35733-35741. PubMed ID: 21865166
[TBL] [Abstract][Full Text] [Related]
18. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.
Kumar KG; Varghese B; Banerjee A; Baker DP; Constantinescu SN; Pellegrini S; Fuchs SY
J Biol Chem; 2008 Jul; 283(27):18566-72. PubMed ID: 18474601
[TBL] [Abstract][Full Text] [Related]
19. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha.
Li S; Labrecque S; Gauzzi MC; Cuddihy AR; Wong AH; Pellegrini S; Matlashewski GJ; Koromilas AE
Oncogene; 1999 Oct; 18(42):5727-37. PubMed ID: 10523853
[TBL] [Abstract][Full Text] [Related]
20. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.
Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S
Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
